# Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer

> **NCT00003732** · PHASE2 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 80 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** paclitaxel
- **DRUG:** topotecan hydrochloride

## Key facts

- **NCT ID:** NCT00003732
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2013-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003732, "Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*